UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.963

Sortiert nach

Dromedary immune response and specific Kv2.1 antibody generation using a specific immunization approach

International journal of biological macromolecules, 2016-12, Vol.93 (Pt A), p.167-171

2016

Link zum Volltext

Verfügbarkeit prüfen

Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism

Computers in biology and medicine, 2023-02, Vol.153, p.106464, Article 106464

2023

Link zum Volltext

Verfügbarkeit prüfen

Computational investigations of hERG channel blockers: New insights and current predictive models

Advanced drug delivery reviews, 2015-06, Vol.86, p.72-82

2015

Link zum Volltext

Verfügbarkeit prüfen

What do we not know about mitochondrial potassium channels?

Biochimica et biophysica acta, 2016-08, Vol.1857 (8), p.1247-1257

2016

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation: Therapeutic potential of atrial K + channel blockers

Pharmacology & therapeutics (Oxford), 2017-08, Vol.176, p.13-21

2017

Link zum Volltext

Verfügbarkeit prüfen

Venom-derived peptide inhibitors of voltage-gated potassium channels

Neuropharmacology, 2017-12, Vol.127, p.124-138

2017

Link zum Volltext

Verfügbarkeit prüfen

Towards a Structural View of Drug Binding to hERG K+ Channels

Trends in pharmacological sciences (Regular ed.), 2017-10, Vol.38 (10), p.899-907

2017

Link zum Volltext

Verfügbarkeit prüfen

Ions and blockers in potassium channels: insights from free energy simulations

Biochimica et biophysica acta, 2005-02, Vol.1747 (1), p.109-120

2005

Link zum Volltext

Verfügbarkeit prüfen

3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel

Bioorganic & medicinal chemistry, 2019-04, Vol.27 (7), p.1292-1307

2019

Link zum Volltext

Verfügbarkeit prüfen

Phenytoin and phenobarbital inhibit human HERG potassium channels

Epilepsy research, 2003, Vol.55 (1), p.147-157

2003

Link zum Volltext

Verfügbarkeit prüfen

Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models

Computers in biology and medicine, 2023-02, Vol.153, p.106491, Article 106491

2023

Link zum Volltext

Verfügbarkeit prüfen

8-hydroxypinoresinol-4-O-β-D-glucoside from Valeriana officinalis L. Is a Novel Kv1.5 Channel Blocker

Journal of ethnopharmacology, 2021-08, Vol.276, p.114168-114168, Article 114168

2021

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel

Journal of pharmacological and toxicological methods, 2016-09, Vol.81 (C), p.251-262

2016

Link zum Volltext

Verfügbarkeit prüfen

Methotrexate, a small molecular scaffold targeting Kv1.3 channel extracellular pore region

Biochemical and biophysical research communications, 2020-11, Vol.532 (2), p.265-270

2020

Link zum Volltext

Verfügbarkeit prüfen

sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity

Biochemical pharmacology, 2022-05, Vol.199, p.115023-115023, Article 115023

2022

Link zum Volltext

Verfügbarkeit prüfen

Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog

Clinical immunology (Orlando, Fla.), 2017-07, Vol.180, p.45-57

2017

Link zum Volltext

Verfügbarkeit prüfen

Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline

Bioorganic & medicinal chemistry, 2019-04, Vol.27 (7), p.1283-1291

2019

Link zum Volltext

Verfügbarkeit prüfen

Structural analysis of hERG channel blockers and the implications for drug design

Journal of molecular graphics & modelling, 2023-05, Vol.120, p.108405, Article 108405

2023

Link zum Volltext

Verfügbarkeit prüfen

Identification of potassium and calcium channel inhibitors as modulators of polyomavirus endosomal trafficking

Antiviral research, 2020-07, Vol.179, p.104819-104819, Article 104819

2020

Link zum Volltext

Verfügbarkeit prüfen

Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo

European journal of pharmacology, 2011-01, Vol.651 (1-3), p.26-32

2011

Link zum Volltext

Verfügbarkeit prüfen

A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties

Biochemical pharmacology, 2011-07, Vol.82 (1), p.81-90

2011

Link zum Volltext

Verfügbarkeit prüfen

The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?

Drug discovery today, 2009-11, Vol.14 (21), p.1011-1020

2009

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of the hERG potassium ion channel by different non-nucleoside human cytomegalovirus polymerase antiviral inhibitor series and the exploration of variations on a pyrroloquinoline core to reduce cardiotoxicity potential

Bioorganic & medicinal chemistry, 2023-05, Vol.85, p.117276-117276, Article 117276

2023

Link zum Volltext

Verfügbarkeit prüfen

Defensins, a novel type of animal toxin-like potassium channel inhibitor

Toxicon (Oxford), 2019-01, Vol.157, p.101-105

2019

Link zum Volltext

Verfügbarkeit prüfen

An anthrone-based Kv7.2/7.3 channel blocker with improved properties for the investigation of psychiatric and neurodegenerative disorders

Bioorganic & medicinal chemistry letters, 2019-12, Vol.29 (23), p.126681, Article 126681

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.963

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.863)
Mit Volltextzugriff
(4.949)

Publikationsform

Artikel
(4.962)
Tagungsberichte
(1)

Sprache

Englisch
(4.963)
Japanisch
(1.096)
Russisch
(3)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.963)
Animals
(4.022)
Biological And Medical Sciences
(2.314)
Rats
(2.006)
Pharmacology & Pharmacy
(1.905)
Neurosciences & Neurology
(1.897)
Male
(1.846)
Neurosciences
(1.823)
Humans
(1.291)
Medical Sciences
(1.269)
Fundamental And Applied Biological Sciences. Psychology
(1.135)
In Vitro Techniques
(1.077)
Potassium Channel Blockers - Pharmacology
(995)
Dose-Response Relationship, Drug
(889)
Pharmacology. Drug Treatments
(869)
Female
(800)
Calcium Channel Blockers - Pharmacology
(783)
Calcium - Metabolism
(771)
Rats, Wistar
(715)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Journal Of Pharmacology
(670)
Neuroscience
(389)
Brain Research
(388)
Neuron
(274)
Life Sciences
(145)
Neuroscience Letters
(145)
Journal Of Molecular And Cellular Cardiology
(144)
Neuropharmacology
(141)
Biochemical And Biophysical Research Communications
(123)
Toxicon
(100)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dromedary immune response and specific Kv2.1 antibody generation using a specific immunization approach

Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism

Computational investigations of hERG channel blockers: New insights and current predictive models

What do we not know about mitochondrial potassium channels?

Atrial fibrillation: Therapeutic potential of atrial K + channel blockers

Venom-derived peptide inhibitors of voltage-gated potassium channels

Towards a Structural View of Drug Binding to hERG K+ Channels

Ions and blockers in potassium channels: insights from free energy simulations

3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel

Phenytoin and phenobarbital inhibit human HERG potassium channels

Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models

8-hydroxypinoresinol-4-O-β-D-glucoside from Valeriana officinalis L. Is a Novel Kv1.5 Channel Blocker

An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel

Methotrexate, a small molecular scaffold targeting Kv1.3 channel extracellular pore region

sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity

Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog

Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline

Structural analysis of hERG channel blockers and the implications for drug design

Identification of potassium and calcium channel inhibitors as modulators of polyomavirus endosomal trafficking

Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo

A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties

The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?

Inhibition of the hERG potassium ion channel by different non-nucleoside human cytomegalovirus polymerase antiviral inhibitor series and the exploration of variations on a pyrroloquinoline core to reduce cardiotoxicity potential

Defensins, a novel type of animal toxin-like potassium channel inhibitor

An anthrone-based Kv7.2/7.3 channel blocker with improved properties for the investigation of psychiatric and neurodegenerative disorders

Aktive Filter

Suchergebnisse filtern